BACKGROUND: Adequacy criteria for thyroid fine-needle aspiration (FNA) recommended by The Bethesda System for Reporting Thyroid Cytopathology (TBS) were developed with smears, but they are commonly applied to ThinPreps (TPs).
INTRODUCTION
Fine-needle aspiration (FNA) of the thyroid is widely accepted as the primary screening test for malignancy in patients with thyroid nodules, and it is used to guide patient management. Only a minority of clinically detectable thyroid nodules are malignant (M), and overtreatment of benign nodules may be avoided with preoperative FNA. [1] [2] [3] Adequacy criteria for thyroid FNA that optimize test sensitivity have varied over the past decades and have not been uniformly accepted or applied between institutions or individual pathologists; this has resulted in reported nondiagnostic (ND) rates ranging from 10% to 35%. 2, [4] [5] [6] [7] [8] [9] The Bethesda System for Reporting Cytopathology (TBS) currently recommends 6 groups of 10 well-visualized follicular cells as minimum adequacy criteria except when diagnostic features of a colloid nodule or inflammatory process are noted. 10 TBS adequacy criteria were based primarily on the work of Goellner and colleagues, 11, 12 who used direct smear preparations before the routine use of ultrasound guidance during aspiration. Although the criteria clearly separated patients into 2 groups with different risks of malignancy, little additional information is available from those studies. The possibility that the criteria were too strict, for example, was not rigorously examined, and this has potentially resulted in a subset of patients with inadequate smears whose risk of malignancy is not increased and who may be subject to unnecessary repeat aspirations with their attendant cost and harm. Subsequently, several studies conducted primarily in the era of ultrasound guidance have suggested that patients with aspirates with as few as 10 or 30 cells lacking atypia or H€ urthle cell changes are not at any increased risk of malignancy in comparison with patients who have met traditional adequacy criteria and can safely be followed without the need for repeat biopsy. 4, 8, 13 Multiple recent studies, primarily from the clinical community rather than cytology community, have shown that the risk of malignancy in patients with ND aspirates is similar to that for patients with benign aspirates, and they suggest following some or all of these patients rather than performing repeat aspiration. [14] [15] [16] [17] Systematic studies evaluating TBS adequacy criteria in ThinPrep (TP) methodology are lacking. Although TP is not used for thyroid FNA examination in all pathology practices, it has become an increasingly popular method of preparation because it allows efficient sample collection and transportation, concentrates the sample into a 20-mm diameter area on 1 slide, eliminates air-drying artifacts, and reduces the amount of obscuring blood present in samples. TP processing has also been purported to alter the presentation of nuclear features and colloid in a manner that could potentially alter the threshold for adequacy in comparison with smear preparations. 18 Therefore, additional data are required to determine whether TBS adequacy criteria are appropriate for TP and result in similar rates of ND results, test sensitivity, and false-negatives (FN). The evaluation of diagnostic accuracy in TP with respect to cellularity is currently limited to a single study. 19 In that study, an examination of 146 cases having a minimum of 6 groups of at least 10 cells each determined that diagnostic accuracy was improved with increased cellularity. The authors recommended a minimum number of 200 cells, which differs significantly from TBS criteria. Whether these results are applicable to thyroid FNA in general rather than cases with at least 60 cells is not known. Adequacy criteria have never been systematically assessed in thyroid TP specimens. Our aim was to examine the cellularity and cytomorphological characteristics of thyroid FNA examined by TP only with an ND diagnosis as determined with current TBS criteria and to determine whether using lower thresholds for diagnostic adequacy would affect the performance characteristics of these specimens.
MATERIALS AND METHODS

Patient Selection and Clinical Characteristics
All FNA procedures performed at Brigham and Women's Hospital (BWH) in Boston, Mass between January 1, 2010 and December 31, 2015 with corresponding surgical resections were analyzed retrospectively with approval of the BWH institutional review board. FNA were performed by an endocrinologist under ultrasound guidance, and material was collected in CytoLyt transport medium (Hologic, Marlborough, Mass). Onsite evaluations were not routinely performed. A single Papanicolaou-stained TP slide was routinely prepared in each case with ThinPrep 2000 (Hologic). ND FNA cases that had at least 1 TP slide available for review and histologic follow-up in the form of lobectomy or total thyroidectomy were included in the study group. Repeat TPs were obtained in a limited number of cases and, when present, were evaluated in conjunction with the original TP slide. Cell blocks, which were not routinely prepared from remaining TP material, were available for only 2 cases and were, therefore, not included in the study analysis. Patient demographic data, ultrasound findings, and surgical follow-up were obtained from the electronic medical record and pathology laboratory information system.
Cytopathology Review
All available TP slides for each ND case were reviewed by one of the authors (M.V.) to assess the following characteristics: cell count, presence of H€ urthle cells, presence of microfollicular or trabecular microarchitecture, nuclear atypia, histiocytoid cells, giant cells, lymphocytes, colloid, hemosiderin-laden macrophages, cyst-lining cells, and blood. All morphologically identifiable follicular cells were included in cell counts; however, for reclassification purposes, a subset was still considered ND if the cells were not well preserved and well visualized. Histiocytoid cells, which have been reported to be associated with papillary thyroid carcinoma (PTC), 20 and cyst-lining cells were excluded from cell counts and scored separately as either present or absent. Six components of nuclear atypia were also scored as either present or absent: isolated enlargement of single nuclei within cell groups, generalized enlargement of nuclei 
RESULTS
Patient Demographic and Diagnostic Characteristics
A total of 1782 FNA procedures with corresponding inhouse surgical resections were performed at BWH between 2010 and 2015 on 877 women and 235 men with a median age of 50 years (range, 15-92 years). Of these, 151 cases (8.5%) were considered ND. One hundred forty-six ND cases were available for review (including 8 cases with repeat TP preparations) from 88 women and 27 men with a median age of 53 years (range, 15-81 years). Sixty-five percent of the ND study cases were obtained by 2 of the 7 endocrinologists practicing at BWH during the study. Patient demographic characteristics, initial or revised cytopathology diagnoses, and surgical pathology diagnoses are listed in Table 1 . There were no differences in sex or age distribution between cases with histologic follow-up that were initially classified as diagnostic and those that were classified as ND (P > .5 for each). Interobserver agreement on the reclassification of ND cases was moderate (k 5 0.57). After reclassification, initially ND cases were more likely to remain ND (33% vs 0%; P <.0001) or be classified as benign (49% vs 38%; P 5 .0072) and less likely to be classified as AUS, SFN/HUR, SUS, or M than cases with surgical follow-up initially considered to be diagnostic (17% vs 61%; P < .0001). No initially ND cases were placed in the SFN/HUR or M categories. A correlation with surgical diagnosis demonstrated that cases initially considered ND were more likely to be benign upon resection than those initially considered diagnostic (81% vs 60%; P < .0001).
Seventy-two of the 146 study patients either did not have additional aspirates before they underwent surgical resection (48 patients) or had at least 1 additional benign diagnosis preceding or following the study case (24 patients). Among these patients, the most common reason for surgical resection following a single ND aspirate or a combination of ND and benign aspirates was relief of compressive symptoms in the setting of multinodular goiter or relief of symptoms of hyperthyroidism (37%); this was followed by findings present in a separate nodule (31%), worrisome radiological findings (15%), patient preference (10%), and surgeon preference (6%).
The remaining patients either had repeated ND FNA (n 5 37) or at least 1 indeterminate thyroid FNA (n 5 37) before resection. The agreement between reclassified ND diagnoses and any prior or subsequent indeterminate or benign FNA was only fair (k 5 0.25). Surgical outcomes, however, correlated with reclassified ND aspirates more often than they did with prior or subsequent diagnostic aspirates (59% vs 41%).
Performance Characteristics of Thyroid FNA With Different Diagnostic Thresholds
Performance characteristics of thyroid FNA were calculated for all diagnostic cases reviewed during the study time period before and after the addition of reclassified ND cases at different cell count thresholds in 10-cell increments without the number or size of the cell groups being taken into account ( Table 2 ). The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and FN rate among all cases initially considered to be diagnostic were 93%, 58%, 59%, 93%, and 7.7%, respectively. Reclassifying cases initially considered to be ND and using different cellularity cutoffs resulted in minimal changes in performance, with sensitivity ranging from 92% to 93%, specificity ranging from 58% to 60%, PPVs ranging from 59% to 60%, NPVs ranging from 92% to 93%, and FN rates ranging from 7.7% to 7.9%.
Diagnostic Factors in Initially ND Cases With >60 cells With Respect to Surgical Outcomes
The median cell count in TPs initially considered to be ND was 41 (range, 0-334), and the mean was 60.5 (standard deviation, 71.4). Of the 146 ND cases, 56 (38%) had a cell count greater than the threshold of 60 suggested by TBS. Factors that resulted in classification as ND included the presence of <6 groups of cells in 24 cases (43%), the presence of <10 cells per cluster in 12 cases (21%), screening errors in 9 cases (16%), poor cell preservation in 6 cases (11%), and obscuring blood in 5 cases (9%; Table  3 ). Most initially ND cases with >60 cells but <6 groups or <10 cells per group were reclassified as benign (79% and 67%, respectively) and had benign outcomes (75% for each); this resulted in a 7.8% FN rate when they were included in performance calculations.
Cytomorphological Characteristics
The cytomorphological characteristics of ND thyroid cases are summarized in Table 4 , and examples are depicted in Figure 1 . Of the nuclear characteristics evaluated, isolated nuclear enlargement (enlargement of single cells within groups of otherwise normal cells) and nonspecific atypia, which typically consisted of isolated nuclei with relative hyperchromasia or nucleoli, were least associated with malignancy (P 5 .2637 and P 5 .5775, respectively). Pseudo-inclusions were rare in these aspirates, with 2 cases associated with PTC and a single case corresponding to a surgical diagnosis of lymphocytic thyroiditis (P 5 .0942).
Other nuclear features that are typically associated with malignancy as defined in TBS, including generalized nuclear enlargement of all cells within cell clusters, nuclear pallor, and nuclear grooves, as well as the presence of histiocytoid cells were appreciable in initially ND samples and were more likely to be seen in M cases (P < .05 for suggest that the overall risk of malignancy for patients with an ND aspirate is so low that they can be followed clinically without repeat aspiration. [14] [15] [16] [17] The consequences of ND FNA must, therefore, be considered when one is developing thyroid FNA adequacy to avoid overtreatment. TBS adequacy criteria for thyroid FNA were developed on smear preparations before the routine use of ultrasound guidance during thyroid FNA, 11, 12 but they are commonly applied to FNA evaluated with liquid-based preparations only. 10, 23, 26 A single study evaluating diagnostic accuracy with respect to cellularity in 146 thyroid FNA cases examined with both smears and TP concluded that a minimum of 200 cells in TP is necessary to optimize diagnostic accuracy and treatment triage. 19 This study, however, eliminated cases initially considered to be ND from an analysis of diagnostic cutoffs, used estimated cell counts, and was performed before the establishment of current TBS diagnostic criteria. No studies have systematically evaluated adequacy criteria in thyroid FNA evaluated with TP alone. Our study design was aimed at a potential redefinition of adequacy criteria in thyroid FNA evaluated with TP alone; we, therefore, counted all cells on each TP and evaluated adequacy cutoffs in increments of 10 cells to determine the lowest cell count that would yield clinically acceptable performance characteristics while minimizing the need for additional invasive procedures. Furthermore, we aimed to address the issue of whether clusters of follicular cells with at least 10 cells, rather than smaller clusters or individually dispersed cells, are truly necessary for diagnosis. The overall ND rate among thyroid FNA cases with surgical follow-up performed at our institution during the study period was 8.5%. ND aspirates were disproportionately obtained by a subset of endocrinologists, and this indicates that limited sampling, rather than cytopathologist-driven interpretive factors, was the major source of ND diagnoses. Adding ND thyroids with at least 1 well-visualized follicular cell that were reclassified into the 6 TBS diagnostic categories back to initially diagnostic FNA at different thresholds resulted in minimal differences in test performance characteristics. Lowering the diagnostic cutoff to 1 well-visualized cell resulted in only a 1% decrease in the test sensitivity and NPV (92% vs 93% for both), a 2% increase in specificity (60% vs 58%), and no change in the PPV. Diagnostic cutoffs intermediate between 1 cell and >60 cells yielded similar results. Notably, we also detected no significant increase from the initial 7.7% FN rate at a cutoff of 1 cell or among cases that had >60 cells but did not have a minimum of 6 groups of 10 cells in comparison with initially diagnostic FNA. These results were obtained upon recategorization of ND cases as AUS or SUS if any features of PTC, follicular neoplasm, or H€ urthle cell neoplasm were present, and indeed, these features were strongly associated with a higher risk of malignancy upon resection with the exception of pseudoinclusions, which were seen in only 3 cases, 1 of which was present in an FNA case that corresponded to a surgical diagnosis of lymphocytic thyroiditis. Our initially ND FNA cases had a high malignancy rate (19%), but this rate is similar to those previously reported (20%-25%) among ND thyroid FNA cases with surgical follow-up using TBS criteria 24, 26, 29 and likely represents a selection bias in the cohort of patients having sufficiently concerning clinical and/or radiological findings to prompt surgical resection (as does the 7.7% malignancy rate in benign aspirates). Of patients in the study group with a single ND FNA or a combination of ND and benign FNA, the majority underwent surgery because of a multinodular goiter or hyperthyroidism rather than worrisome clinical findings. Acellular ND aspirates in patients who underwent surgery had only a 11% malignancy rate, and this suggests that this group may have a lower malignancy risk than patients with ND nodules containing follicular cells, although this trend was not statistically significant. Particularly in patients undergoing thyroid FNA with ultrasound guidance, therefore, it is possible that a complete lack of follicular cells may be indicative of the presence of an underlying lower risk lesion rather than merely representing a sampling error. Among the follicular cell-containing aspirates, we reclassified 23% (25 of 110) into an indeterminate category (primarily AUS). This reflects our attempt within the study setting to avoid using the ND category when wellvisualized and well-preserved follicular cells were present, but it also suggests that in our actual clinical practice, cytopathologists often opt to use the ND diagnosis in lieu of the AUS category when they are confronted with a paucicellular specimen. This tradeoff between the use of the ND and AUS diagnoses has been previously described 31 and is not surprising in this context because limited specimen cellularity is a common contributing factor to an AUS diagnosis. If the cellularity threshold for adequacy were lowered, it is probable that there would be some increase in AUS diagnoses in these low-cellularity specimens. In the current study, however, only a 0.9% increase in the AUS rate was observed after reclassification, in contrast to a 3.8% increase in benign diagnoses and a 5.4% decrease in the ND rate, and the minimal increase in the AUS rate could be acceptable to avoid overtreatment in the larger number of ND cases that would be reclassified as benign. From a treatment perspective, an increase in AUS diagnoses may lead to repeat thyroid FNA just as an ND diagnosis would. Alternatively, an AUS diagnosis could prompt molecular testing on separately obtained FNA material or on residual TP material (which may yield valid results even on ND aspirates, albeit at a lower rate of success) and thereby prevent additional unnecessary procedures. 32, 33 Most importantly, our results indicate that the current TBS recommendation of 6 groups of follicular cells with at least 10 cells per group represents an excessively stringent adequacy threshold for thyroid FNA evaluated with TP alone. These findings are similar to those found previously for thyroid FNA evaluated with smears, for which the proposed adequacy threshold was 10 or 30 cells. 4, 8, 13 In fact, our data indicate that finding essentially any well-visualized follicular cells without worrisome morphological features is sufficient to warrant a benign diagnosis. With the adequacy criteria lowered to any follicular cells, 66% of all ND aspirates (97 of 146) in our cohort would have been considered diagnostic with this minimal threshold, and 50% of the patients with initially ND results could have avoided unnecessary additional procedures.
As a practical matter, however, we recognize that most cytopathologists would feel uncomfortable making a benign diagnosis solely on the basis of the evaluation of a single thyroid follicular cell. Simply changing the adequacy criteria to 60 follicular cells without specifically requiring 6 groups of 10 cells each would result in the reclassification of approximately half of the ND cases in our study that contained any follicular cells (56 of 110 or 51%). To take the more aggressive approach of lowering the adequacy threshold below 60 follicular cells, as supported by our data and previous data, 4, 8, 13 one could reasonably require a minimal assessment of both nuclear and architectural features of the follicular cells. Accordingly, more realistic criteria for a benign but sparsely cellular aspirate would be as follows: 1) a minimum of 10 follicular cells in total (as proposed to be an acceptable lower limit on smears), 4, 8, 13 2) at least 1 cluster of follicular cells in a macrofollicular or flatsheet configuration lacking architectural atypia (microfollicular or crowded pattern), 3) the absence of H€ urthle cell change (although not associated with malignancy in our cohort, in a prior study, extensive H€ urthle cell change was associated with malignancy in a subset of reclassified ND cases 4 ), and 4) the absence of any nuclear features associated with PTC. This redefinition of minimal specimen adequacy would be applicable to preparations evaluated with TP, smears, or a combination of the two. Any lingering reluctance to render a benign diagnosis with such paucicellular aspirates would be mitigated by an explanatory note. This note would indicate that the specimen is sparsely cellular and, similarly to our prior proposal, recommend correlation of the cytological, clinical, and radiological findings with clinical follow-up as appropriate. 34 Most importantly, this approach would appropriately reclassify many limited-cellularity aspirates currently considered ND with evidence-based criteria and, in doing so, would spare many patients from additional procedures, including the possibility of unnecessary surgery.
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